TD Cowen Maintains Hold on Myriad Genetics, Raises Price Target to $4.50
TD Cowen raised its price target to $4.50 per share from $4.00 while maintaining its Hold rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.